Morning Buzz: Facebook (FB), Kite Pharma (KITE), XOMA Corp. (XOMA), Digital Ally (DGLY), SunEdison (SUNE)


Facebook (FB) — The social networking giant is planning to launch in coming months a professional version of its social network site, a company executive told Reuters.

Shares of Kite Pharma, Inc. (KITE) are lower by more than 3% to $67.64 in pre-market trading on Thursday following the company’s pricing of its underwritten public offering of 3.625 million shares at $69.00/shr. The gross proceeds to Kite from the offering are expected to be approximately $250.1 million.

XOMA Corporation (XOMA) shares surged 4.83% to $1.41 in pre-market trading on news of a settlement and amended license agreement with Pfizer (PFE).

Under the terms of the original License Agreement, effective as of August 27, 2007, by and between XOMA Ireland Limited and Pfizer Inc., XOMA received an upfront, non-dilutive cash payment of $30 million and was eligible for potential milestone, royalty and other fees on future sales of all products subject to this license, including products currently in late-stage clinical development.

Shares of Digital Ally Inc. (DGLY) are up $0.75, or 16.48%, at $5.30, after the company this morning reported that the USPTO has rejected a challenge by Taser International (TASR) aimed at invalidating Digital Ally’s ‘292 patent directed to law enforcement camera auto-activation.

SunEdison, Inc. (SUNE) +2.5%, $4.06 – The company announced that it has signed a 10-year agreement with Ontario’s Independent Electricity System Operator to supply 5 megawatts—20 megawatt-hours—of battery storage to the province.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.